Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
PHASE1CompletedINTERVENTIONAL
Enrollment
98
Participants
Timeline
Start Date
Not specified
Study Completion Date
July 31, 1996
Conditions
HIV InfectionsAnus Neoplasms
Interventions
DRUG
Isotretinoin
DRUG
Interferon alfa-2a
Trial Locations (1)
98122
University of Washington AIDS CRS, Seattle
All Listed Sponsors
collaborator
Hoffmann-La Roche
INDUSTRY
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000764 - Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. | Biotech Hunter | Biotech Hunter